JP2022069446A5 - - Google Patents

Download PDF

Info

Publication number
JP2022069446A5
JP2022069446A5 JP2022017497A JP2022017497A JP2022069446A5 JP 2022069446 A5 JP2022069446 A5 JP 2022069446A5 JP 2022017497 A JP2022017497 A JP 2022017497A JP 2022017497 A JP2022017497 A JP 2022017497A JP 2022069446 A5 JP2022069446 A5 JP 2022069446A5
Authority
JP
Japan
Prior art keywords
fragment
analyte
control
light chain
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022017497A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022069446A (ja
JP7541045B2 (ja
Filing date
Publication date
Priority claimed from GBGB1603291.4A external-priority patent/GB201603291D0/en
Application filed filed Critical
Publication of JP2022069446A publication Critical patent/JP2022069446A/ja
Publication of JP2022069446A5 publication Critical patent/JP2022069446A5/ja
Application granted granted Critical
Publication of JP7541045B2 publication Critical patent/JP7541045B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022017497A 2016-02-25 2022-02-07 質量分析キット Active JP7541045B2 (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB1603291.4 2016-02-25
GBGB1603291.4A GB201603291D0 (en) 2016-02-25 2016-02-25 Antibodies
US201662368606P 2016-07-29 2016-07-29
US62/368,606 2016-07-29
PCT/GB2017/050489 WO2017144900A1 (en) 2016-02-25 2017-02-24 Mass spectrometry kit
JP2018544901A JP7246927B2 (ja) 2016-02-25 2017-02-24 質量分析キット

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018544901A Division JP7246927B2 (ja) 2016-02-25 2017-02-24 質量分析キット

Publications (3)

Publication Number Publication Date
JP2022069446A JP2022069446A (ja) 2022-05-11
JP2022069446A5 true JP2022069446A5 (cg-RX-API-DMAC7.html) 2023-09-15
JP7541045B2 JP7541045B2 (ja) 2024-08-27

Family

ID=55806928

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018544901A Active JP7246927B2 (ja) 2016-02-25 2017-02-24 質量分析キット
JP2022017497A Active JP7541045B2 (ja) 2016-02-25 2022-02-07 質量分析キット
JP2022198753A Active JP7541070B2 (ja) 2016-02-25 2022-12-13 質量分析キット

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2018544901A Active JP7246927B2 (ja) 2016-02-25 2017-02-24 質量分析キット

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022198753A Active JP7541070B2 (ja) 2016-02-25 2022-12-13 質量分析キット

Country Status (10)

Country Link
US (2) US12461108B2 (cg-RX-API-DMAC7.html)
EP (2) EP3420361B1 (cg-RX-API-DMAC7.html)
JP (3) JP7246927B2 (cg-RX-API-DMAC7.html)
KR (1) KR102851057B1 (cg-RX-API-DMAC7.html)
CN (2) CN108885218A (cg-RX-API-DMAC7.html)
AU (1) AU2017222399B2 (cg-RX-API-DMAC7.html)
DK (1) DK3420361T3 (cg-RX-API-DMAC7.html)
ES (1) ES2936783T3 (cg-RX-API-DMAC7.html)
GB (1) GB201603291D0 (cg-RX-API-DMAC7.html)
WO (1) WO2017144900A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201708262D0 (en) * 2017-05-23 2017-07-05 Binding Site Group Ltd Assay for plasma cell associated disease
CA3126712A1 (en) * 2019-01-31 2020-08-06 Regeneron Pharmaceuticals, Inc. Native microfluidic ce-ms analysis of antibody charge heterogeneity
CN110009008B (zh) * 2019-03-18 2020-11-06 四川大学 基于提取的免疫固定电泳图特征对其进行自动分类的方法
GB201906599D0 (en) 2019-05-10 2019-06-26 Binding Site Group Ltd Mass spectrometry calibrator
US12474351B2 (en) * 2019-05-10 2025-11-18 The Binding Site Group Limited Mass spectrometry calibrator
GB201915946D0 (en) 2019-11-01 2019-12-18 Binding Site Group Ltd Quantitation of immunoglobulins i n mass spectrometry
GB202007047D0 (en) * 2020-05-13 2020-06-24 Binding Site Group Ltd Mass spectrometry controls
GB202008887D0 (en) * 2020-06-11 2020-07-29 Binding Site Group Ltd A method of identifying or characterising an immune response in a subject
GB202016822D0 (en) 2020-10-23 2020-12-09 Binding Site Group Ltd Quantitation of immunoglobulins in mass spectrometry
CN113720900A (zh) * 2021-09-14 2021-11-30 首都医科大学附属北京朝阳医院 一种基于madli-tof ms技术检测血清中m蛋白的方法
CN114324557B (zh) * 2021-12-03 2024-05-10 融智生物科技(青岛)有限公司 一种基于MALDI-TOF MS的ζ-珠蛋白的检测方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991003493A1 (en) 1989-08-29 1991-03-21 The University Of Southampton Bi-or trispecific (fab)3 or (fab)4 conjugates
WO1991006570A1 (en) * 1989-10-25 1991-05-16 The University Of Melbourne HYBRID Fc RECEPTOR MOLECULES
EP0590058B1 (en) * 1991-06-14 2003-11-26 Genentech, Inc. HUMANIZED Heregulin ANTIBODy
AU691297B2 (en) * 1994-05-13 1998-05-14 Miltenyi Biotec Gmbh Sterile and pyrogen-free columns coupled to protein for binding and removal of substances from blood
JP2826965B2 (ja) * 1995-01-12 1998-11-18 オリエンタル酵母工業株式会社 免疫吸着体とその製造法
WO1997017372A1 (en) 1995-11-03 1997-05-15 The Binding Site Limited Production of antibodies, and medical uses involving antibodies
US6207370B1 (en) * 1997-09-02 2001-03-27 Sequenom, Inc. Diagnostics based on mass spectrometric detection of translated target polypeptides
US6897044B1 (en) 1999-01-28 2005-05-24 Biogen Idec, Inc. Production of tetravalent antibodies
US20050142609A1 (en) * 2003-10-08 2005-06-30 Ebioscience Native immunoglobulin binding reagents and methods for making and using same
GB0501741D0 (en) * 2005-01-27 2005-03-02 Binding Site The Ltd Antibody
CA2600844A1 (en) * 2005-03-14 2006-09-21 Medimmune, Inc. Macromolecules comprising a thioether cross-link
US7781178B2 (en) 2005-04-12 2010-08-24 Akira Matsumori Biomarker for diagnosing heart disease and the use thereof
US7893616B2 (en) * 2006-02-27 2011-02-22 Ohio State University Process to determine enzyme activity
WO2008079914A1 (en) 2006-12-21 2008-07-03 Novartis Ag Antibody quantitation
BR112012007815A2 (pt) 2009-10-09 2018-03-20 Symphogen As quantificação multiplex de proteínas recombinantes em uma mistura por peptídeos de assinatura e espectrometria de massa.
GB201001946D0 (en) 2010-02-05 2010-03-24 Binding Site Group The Ltd Cancer prognostic assay
GB2478520A (en) 2010-03-02 2011-09-14 Binding Site Group Ltd Kidney prognostic assay
GB201117172D0 (en) 2011-10-05 2011-11-16 Binding Site Group The Ltd Diabetes
GB201121265D0 (en) 2011-12-12 2012-01-18 Binding Site Group The Ltd Assay
CA2866699A1 (en) * 2012-03-09 2013-09-12 Ucl Business Plc Chemical modification of antibodies
WO2014121031A1 (en) * 2013-01-31 2014-08-07 Excelimmune, Inc. Characterization of antibody mixtures by mass spectrometry
WO2015131169A2 (en) * 2014-02-28 2015-09-03 H. Lee Moffitt Cancer Center And Research Institute, Inc. Personalized myeloma detection
JP6759104B2 (ja) * 2014-04-04 2020-09-23 メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ 精密分子質量を用いた免疫グロブリンのアイソタイピング
US10690676B2 (en) * 2014-07-29 2020-06-23 Mayo Roundation for Medical Education and Research Quantifying monoclonal antibody therapeutics by LC-MS/MS
DK3209767T3 (da) * 2014-10-21 2020-11-02 Gennova Biopharmaceuticals Ltd Hidtil ukendt oprensningsfremgangsmåde til isolering og kommerciel fremstilling af rekombinant tnk-tpa (tenecteplase)
JP6968058B2 (ja) 2015-09-24 2021-11-17 メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ 質量分析法による免疫グロブリン遊離軽鎖の同定
GB201708262D0 (en) * 2017-05-23 2017-07-05 Binding Site Group Ltd Assay for plasma cell associated disease

Similar Documents

Publication Publication Date Title
JP2023033281A5 (cg-RX-API-DMAC7.html)
JP7541070B2 (ja) 質量分析キット
JP2021042257A5 (cg-RX-API-DMAC7.html)
Atmanene et al. Extending mass spectrometry contribution to therapeutic monoclonal antibody lead optimization: characterization of immune complexes using noncovalent ESI-MS
JP2005539067A5 (cg-RX-API-DMAC7.html)
JP2018526642A (ja) リン酸化アルファ−シヌクレインを検出するための方法
JP2019509483A5 (cg-RX-API-DMAC7.html)
JP2016540212A (ja) 多価多重特異性分子の生物学的活性を決定するためのsprベースの架橋アッセイ
US20250231191A1 (en) Lc-ms methods for antibody isotyping and quantification
Peronnet et al. SELDI‐TOF MS analysis of the Cardiac Troponin I forms present in plasma from patients with myocardial infarction
US20080176254A1 (en) Affinity separation compositions and methods
JP2020170001A (ja) エフェクター機能抑制型ヒトまたはヒト化薬物抗体に対する抗薬物抗体の決定方法
Tam et al. Depletion and fractionation technologies in plasma proteomic analysis
US20050003360A1 (en) Array systems and methods
JP5821198B2 (ja) 抗il28b抗体及びこれを用いたil28bの測定方法
Chen et al. Aleuria Aurantia Lectin (AAL)-reactive immunoglobulin G rapidly appears in sera of animals following antigen exposure
CN117304327A (zh) 一种抗山羊IgG的兔单克隆抗体及其应用
EP3856347A1 (en) Antibody quantification in biological samples
JP6420281B2 (ja) タンパク質解析用固相担体及びその製造方法
KR20240032972A (ko) 위치 선택적 다이메틸화에 의한 단백질 n-말단 신규 서열분석
WO2025207846A1 (en) Methods for characterizing proteins in serum samples
WO2026079160A1 (ja) 抗体の分析方法
JP2005030852A (ja) 間質性肺炎診断剤およびこれを含有する間質性肺炎診断用キット
EP4194054A1 (en) Camelid antibodies for use in therapy and diagnosis
JP6548115B2 (ja) 動脈硬化症マーカー及びその利用